COVID-19 Immunologic Antiviral Therapy With Omalizumab
Clinical trial NCT04720612 · UNKNOWN
Trial details
- NCT number
- NCT04720612
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2022-11-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.